These findings suggest that IL-1RA and B-NGF could serve as novel biomarkers for early detection and disease monitoring of thyroid cancer, while M-CSF could be a potential therapeutic target, providing theoretical support for personalised intervention strategies. Here, NGF is linked to thyroid gland carcinoma.